University of Kentucky - College of Pharmacy
Specialty Natural Products Available
In addition to the exclusive UK Natural Products Repository within CPRI, overproduction strains for various bioactive natural product-based probes, drug lead candidates and/or drugs have been identified as part of the CPRI microbial natural product discovery effort. Currently, the following pure natural products are in stock and available to support translational research activities. Please contact us for more information.
- Actinomycin D (Dactinomycin, Chounghwamycin B, Cosmegen, Meractinomycin, NCI C04682)
- AT2433-A1
- AT2433-B1
- Coumabiocin A
- Elaiophylin (Azalomycin B, Salbomycin, Gopalamicin, SNA-4606-3)
- Geldanamycin (NSC 122750, NSC 212518)
- 19-Hydroxy-geldanamycin
- Herbicidin A
- Herbicidin B
- Herbimycin A (NSC 305978, Antibiotic TAN 420F)
- Mithramycin A (Plicamycin, Plicatomycin, Mithracin, NSC 24559, Aureolic acid)
- Mithramycin SA
- Mithramycin SK
- Nocardamine (Deferrioxamine E, Deferriferrioxamine E, Desferrioxamine E, Proferrioxamine E)
- Novobiocin (Albamycin, Cathomycin, Streptonivicin, Inamycin, Cardelmycin, Sirbiocina)
- Oxachelin
- Scopafungin (Nificin, Niphimycin I alpha, NSC 107041, U 29479)
- Venturicidin A (Aabomycin A1, Venturicidin B-3'-carbamate)
- Venturicidin B (Aabomycin A2)
Opportunities
We welcome inquiries from UK investigators interested in exploring the potential of novel natural products within the context of emerging research partnerships and collaborations. For more information and to request services, please contact us.